Nine Catalysts For China Biopharma In 2019
Jan 09 2019
•
By
Brian Yang
Shanghai Leads China's Massive "4+7" Centralized Bidding Scheme. • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from China
More from Focus On Asia
